Good Life Sciences Generations — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Evanston, US
Henry White(Executive Officer, Director)Vikas Nandwana(Executive Officer, Director)Vinayak Dravid(Executive Officer, Director)
Board seatDavid Mendez· per SEC Form D · $4M raise · filed Aug 2025
OrbitalRX provides a cloud-based platform for hospital pharmacy teams to manage drug shortages through centralized workflows and predictive intelligence.
Enterprise SoftwareHealthtechSaaS
Board seatRobert Crutchfield· per SEC Form D · $2.5M raise · filed Oct 2025
Co-investorsAlerion VenturesExcelerate Health VenturesThe Launch Place
BiotechWayzata, US
Martin L. Mayse(Executive Officer, Director, Promoter)
BoardRichard Stark(Director)Gintaras Vaisnys(Director)Mark Deem(Director)
Board seatRobert Crutchfield· per SEC Form D · $4M raise · filed Nov 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.